These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential. Huang R; Liu Z; Sun T; Zhu L Microbiol Res; 2024 Oct; 287():127857. PubMed ID: 39121703 [TBL] [Abstract][Full Text] [Related]
4. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs. van de Wijgert J; Verwijs MC BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136 [TBL] [Abstract][Full Text] [Related]
5. Ansari A; Son D; Hur YM; Park S; You YA; Kim SM; Lee G; Kang S; Chung Y; Lim S; Kim YJ Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111086 [TBL] [Abstract][Full Text] [Related]
6. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis. Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809 [TBL] [Abstract][Full Text] [Related]
7. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study. Vasundhara D; Raju VN; Hemalatha R; Nagpal R; Kumar M Indian J Med Res; 2021 Apr; 153(4):492-502. PubMed ID: 34380796 [TBL] [Abstract][Full Text] [Related]
8. Vaginal Microbiota. Mendling W Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352 [TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of Cervical and Vaginal Microbiota Associated With Cervical Intraepithelial Neoplasia. Lin S; Zhang B; Lin Y; Lin Y; Zuo X Front Cell Infect Microbiol; 2022; 12():767693. PubMed ID: 35237529 [TBL] [Abstract][Full Text] [Related]
10. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Nené NR; Reisel D; Leimbach A; Franchi D; Jones A; Evans I; Knapp S; Ryan A; Ghazali S; Timms JF; Paprotka T; Bjørge L; Zikan M; Cibula D; Colombo N; Widschwendter M Lancet Oncol; 2019 Aug; 20(8):1171-1182. PubMed ID: 31300207 [TBL] [Abstract][Full Text] [Related]
11. [Effect of oral Liu Y; Huang Y; Cai W; Li D; Zheng W; Xiao Y; Liu Y; Zhao H; Pan S Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1753-1759. PubMed ID: 33380389 [TBL] [Abstract][Full Text] [Related]
12. Impact of oral administration of four de Vrese M; Laue C; Papazova E; Petricevic L; Schrezenmeir J Benef Microbes; 2019 May; 10(5):483-496. PubMed ID: 31012733 [TBL] [Abstract][Full Text] [Related]
13. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis. Pino A; Rapisarda AMC; Vitale SG; Cianci S; Caggia C; Randazzo CL; Cianci A Sci Rep; 2021 Jan; 11(1):2592. PubMed ID: 33510271 [TBL] [Abstract][Full Text] [Related]
14. The microbiome and gynaecological cancer development, prevention and therapy. Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434 [TBL] [Abstract][Full Text] [Related]
20. The Need to Focus on Therapy Instead of Associations. Reid G Front Cell Infect Microbiol; 2019; 9():327. PubMed ID: 31572693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]